Persistent cyanosis in newborn occurs commonly due to congenital heart diseases, most of them present with cyanosis in early neonatal period. Herein we report a rare case of late onset persistent cyanosis in a neonate due to a large mass in right atrium caused by fungal endocarditis.
BenjaminDKJr, PooleC, SteinbachWJ, . Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics. 2003;112:634–640.
2.
PanaZD, KougiaV, RoilidesE.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update. Expert Opin Pharmacother. 2015;16:693–710.
3.
KothariSS, SharmaM, SaxenaA, SharmaR.Right atrial mass due to fungal endocarditis in an infant. Indian Pediatr. 1996;33:593–595.
4.
ParkerJCJr.The potentially lethal problem of cardiac candidosis. Am J Clin Pathol. 1980;73:356–361.
5.
FernandezM, MoylettEH, NoyolaDE, . Candidal meningitis in neonates: a 10-year review. Clin Infect Dis. 2000;31:458–463.
6.
MillarBC, JugoJ, MooreJE.Fungal endocarditis in neonates and children. Pediatr Cardiol. 2005;26:517–536.
7.
Fernández GuerreroML, ÁlvarezB, ManzarbeitiaF, . Infective endocarditis at autopsy: a review of pathologic manifestations and clinical correlates. Medicine (Baltimore). 2012;91:152–164.
8.
KossEH, BuescherES, KarlowiczMG.Candidemia in neonatal intensive care unit: trend during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17:504e508.
9.
FaixRG.Systemic Candida infections in infants in intensive care nurseries, high incidence of central nervous system involvement. J Pediatr. 1984;105:616e622.
10.
ZenkerPN, RosenbergEM, Van DykeRB, . Successful medical treatment of presumed Candida endocarditis in critically ill infants. J Pediatr. 1991;119:472e477.
11.
MilllardDD, ShulmanST.The changing spectrum of neonatal endocarditis. Clin Perinatol. 1988;15:587e608.
12.
SymchychPS, KraussAN, WinchesterP.Endocarditis following intracardiac placement of umbilical venous catheters in neonates. J Pediatr. 1977;90:287e289.
13.
OelbergDG, FisherDJ, grossDM, . Endocarditis in high-risk neonates. Pediatrics. 1983;71:392e397.
14.
FerrieriP, GewitzMH, GerberMA, . Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association Council on Cardiovascular Disease in the Young. Unique features of infective endocarditis in childhood. Circulation. 2002;105:2115–2126.
15.
HopeWW, CastagnolaE, GrollAH, . ESCMID Fungal Infection Study Group. ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012;18:38–52.
16.
CaudleKE, IngerAG, ButlerDR, . Echinocandin use in neonatal intensive care unit. Ann Pharmacother. 2012;46:108–116.
17.
MohamedWA, IsmailM.A randomized, double-blind, prospective study of caspofungin vs. amphotericin B for the treatment of invasive candidiasis in newborn infants. J Trop Pediatr. 2012;58:25–30.
18.
ManzoniP, RizzolloS, FrancoC, . Role of echinocandins in the management of fungal infections in neonates. J Matern Fetal Neonatal Med. 2010;23(Suppl 3):49–52.
19.
NomuraF, PennyDJ, MenahemS, . Surgical intervention for infective endocarditis in infancy and childhood. Ann Thorac Surg. 1995;60:90–95.
20.
WarrisA, LehrnbecherT, RoilidesE, . ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin Microbiol Infect. 2019Sep;25(9):1096–1113.
21.
GanesanV, PonnusamySS, SundaramurthyR.Fungal endocarditis in paediatrics: a review of 192 cases (1971–2016). Cardiol Young. 2017;27:1–7.
